Apotex Inc.

48 patents currently held · Updated Nov 14, 2026

7 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Nov 2026

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

2 fees due Nov 28 to 30, 2026 · next Nov 28
1 fee due Dec 6, 2026
The maintenance fee for Crystalline Forms of Tenofovir Alafenamide (US 11,667,656) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
4 fees due Jan 7 to 16, 2027 · next Jan 7
1 fee due Feb 25, 2027
The maintenance fee for Treating Patients with Intravenous Ibuprofen (US 9,114,068) comes due Feb 25, 2027. Unpaid by Aug 25, 2027, it lapses early.
2 fees due Mar 10 to 22, 2027 · next Mar 10
3 fees due May 7 to 26, 2027 · next May 7
2 fees due Jun 24, 2027
1 fee due Aug 11, 2027
The maintenance fee for Processes for the Preparation of Veliparib and Intermediates Thereof (US 10,556,887) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
1 fee due Sep 29, 2027
The maintenance fee for Treating Critically Ill Patients with Intravenous Ibuprofen (US 9,295,639) comes due Sep 29, 2027. Unpaid by Mar 29, 2028, it lapses early.
2 fees due Oct 7 to 28, 2027 · next Oct 7
1 fee due Nov 3, 2027
The maintenance fee for Acetylcysteine Compositions and Methods of use Thereof (US 9,327,028) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 16, 2026
2 terms have ended since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 8,003,755	Hydrochloride Salts of a Glycopeptide Phosphonate Derivative In force Term ends Nov 22, 2026 · High confidence	In force	Term ends Nov 22, 2026	High confidence
US 7,531,623	Hydrochloride Salts of a Glycopeptide Phosphonate Derivative In force Term ends Jan 1, 2027 · High confidence	In force	Term ends Jan 1, 2027	High confidence
US 9,649,284	Treating Critically Ill Patients with Intravenous Ibuprofen In force Term ends Aug 2, 2027 · Medium confidence	In force	Term ends Aug 2, 2027	Medium confidence
US 7,816,355	Processes for the Preparation of Rivaroxaban and Intermediates Thereof In force Term ends Apr 28, 2029 · High confidence	In force	Term ends Apr 28, 2029	High confidence
US 8,101,609	Processes for the Preparation of Rivaroxaban and Intermediates Thereof In force Term ends Apr 28, 2029 · High confidence	In force	Term ends Apr 28, 2029	High confidence
US 8,735,452	Treating Patients with Intravenous Ibuprofen In force Term ends Sep 30, 2029 · Medium confidence	In force	Term ends Sep 30, 2029	Medium confidence
US 9,114,068	Treating Patients with Intravenous Ibuprofen In force Term ends Sep 30, 2029 · Medium confidence	In force	Term ends Sep 30, 2029	Medium confidence
US 9,138,404	Treating Critically Ill Patients with Intravenous Ibuprofen In force Term ends Sep 30, 2029 · Medium confidence	In force	Term ends Sep 30, 2029	Medium confidence
US 9,295,639	Treating Critically Ill Patients with Intravenous Ibuprofen In force Term ends Sep 30, 2029 · Medium confidence	In force	Term ends Sep 30, 2029	Medium confidence
US 9,931,311	Treating critically ill patients with intravenous ibuprofen In force Ends no later than Sep 30, 2029 · From the USPTO record	In force	Ends no later than Sep 30, 2029	From the USPTO record

10 of 48 patents shown.

Pro members see all 48.

Pro members: see all 48 patents

Also on record, not counted in the 48: 7 patents in force now held by others · 33 lapsed for an unpaid fee · 19 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 6 abandoned · 14 no status recorded

List them